December 16, 2018

Enrollment is now open for a new treatment for diabetic macular edema(DME)!  This is  important as diabetes affects 30,000,000 Americans and  DME affects at least 750,000. The new drug, may be superior to existing treatments,and may require much less frequent administration.The study is a phase 3 and is sponsored through Genentech and the drug is called faricimab.  To learn more, contact us at Island Retina.  If you or a loved one has diabetes bring them to Island Retina for a screening. It is possible to have advanced disease that needs treatment to prevent progression to blindness, before you have symptoms. Sometimes you may notice blurring, increased floaters or problems with reading and driving.